A Multicenter, Observational Study to Investigate Sputum Inflammation Phenotyping and Predict Clinical Outcomes in Non-Cystic Fibrosis Bronchiectasis, with Subsequent Participation in the HSK31858 Clinical Trial
Latest Information Update: 10 Dec 2024
Price :
$35 *
At a glance
- Drugs HSK 31858 (Primary)
- Indications Bronchiectasis
- Focus Therapeutic Use
- 10 Dec 2024 New trial record